Chiome Bioscience (TSE:4583) Days Sales Outstanding : 46.76 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience Days Sales Outstanding?

Chiome Bioscience's average Accounts Receivable for the three months ended in Mar. 2024 was 円66.4 Mil. Chiome Bioscience's Revenue for the three months ended in Mar. 2024 was 円129.6 Mil. Hence, Chiome Bioscience's Days Sales Outstanding for the three months ended in Mar. 2024 was 46.76.

The historical rank and industry rank for Chiome Bioscience's Days Sales Outstanding or its related term are showing as below:

TSE:4583' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.05 Med: 56.85 Max: 73.76
Current: 46.31

During the past 13 years, Chiome Bioscience's highest Days Sales Outstanding was 73.76. The lowest was 21.05. And the median was 56.85.

TSE:4583's Days Sales Outstanding is ranked better than
72.36% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs TSE:4583: 46.31

Chiome Bioscience's Days Sales Outstanding declined from Mar. 2023 (56.27) to Mar. 2024 (46.76).

Chiome Bioscience Days Sales Outstanding Historical Data

The historical data trend for Chiome Bioscience's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience Days Sales Outstanding Chart

Chiome Bioscience Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

56.04

57.66

21.05

40.70

53.06

Chiome Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															56.27	45.90	50.06	48.23	46.76

Competitive Comparison of Chiome Bioscience's Days Sales Outstanding

For the Biotechnology subindustry, Chiome Bioscience's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chiome Bioscience's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's Days Sales Outstanding falls into.

Chiome Bioscience Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Chiome Bioscience's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (115.218	+	83.193)	/	2 )	/	682.464	*	365
=	99.2055					/	682.464	*	365
=	53.06

Chiome Bioscience's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (83.193	+	49.666)	/	2 )	/	129.644	*	365 / 4
=	66.4295					/	129.644	*	365 / 4
=	46.76

Chiome Bioscience (TSE:4583) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Chiome Bioscience Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Chiome Bioscience (TSE:4583) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071

Website

http://www.chiome.co.jp

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience (TSE:4583) Headlines

No Headlines